Antibiotice S.A. (BVB:ATB)
Romania · Delayed Price · Currency is RON 1.798
-0.002 (-0.11%)
At close: Apr 7, 2026
Antibiotice Revenue
In the year 2025, Antibiotice had annual revenue of 660.04M RON, down -4.16%. Antibiotice had revenue of 183.26M in the quarter ending December 31, 2025, with 6.44% growth.
Revenue
660.04M
Revenue Growth
-4.16%
P/S Ratio
1.83
Revenue / Employee
487.11K
Employees
1,356
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 660.04M | -28.66M | -4.16% |
| Dec 31, 2024 | 688.70M | 73.41M | 11.93% |
| Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
| Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
| Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alro S.A. | 3.90B |
| Sphera Franchise Group | 1.58B |
| Teraplast | 1.08B |
| TTS (Transport Trade Services) | 655.14M |
| Aerostar | 623.22M |
| Fondul Proprietatea | 484.50M |
| Infinity Capital Investments | 331.30M |
| Biofarm | 319.33M |